Literature DB >> 33544434

Multi-drug resistance in Streptococcus pneumoniae among children in rural Vietnam more than doubled from 1999 to 2014.

Mattias Larsson1,2, Hoa Quynh Nguyen3, Linus Olson1,2,4, Toan Khanh Tran5, Trung Vu Nguyen6, Chuc Thi Kim Nguyen2,5.   

Abstract

AIM: This study assessed the Streptococcus pneumoniae colonisation rate and susceptibility to antibiotics among preschool children in rural Vietnam.
METHOD: Nasopharyngeal samples were collected from 546 preschool children aged 6-59 months living in 460 households in the rural BaVi District of Hanoi and their main caregivers completed questionnaires. The samples were cultured, and the Streptococcus pneumoniae colonisation rate and antibiotic susceptibility were investigated. Resistance data from this 2014 study were compared with studies in 1999 and 2007, to identify 15-year trends, together with clinical isolates from a national surveillance system of 16 Vietnamese hospital laboratories established in 2013.
RESULTS: We found that 221/546 (40%) of the cultures were positive for Streptococcus pneumoniae. The susceptibility rates were trimethoprim-sulphamethoxazole (5%), erythromycin (8%), ciprofloxacin (12%), benzyl-penicillin (35%), tetracycline (49%), cefotaxime (55%), moxifloxacin (99%) and vancomycin (99%). All the susceptibility rates were lower in 2014 than 1999 and 2007, except tetracycline. Multi-drug resistance was 80% in 2014, compared to 60% in 2007 and 31% in 1999. Antibiotics was reported used by 191 (35%) within one month, mainly cephalosporins 86 (45%), amoxycillin/ampicillin 69 (36%) and macrolides 30 (16%).
CONCLUSION: Streptococcus pneumoniae showed remarkable high resistance to commonly used antibiotics, including cephalosporins. Multi-drug resistance rose from 31% to 80% during the 15-year study period.
© 2021 The Authors. Acta Paediatrica published by John Wiley & Sons Ltd on behalf of Foundation Acta Paediatrica.

Entities:  

Keywords:  zzm321990Streptococcus pneumoniaezzm321990; Vietnam; antibiotic resistance; carriage rate; multi-drug resistance

Year:  2021        PMID: 33544434     DOI: 10.1111/apa.15795

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  4 in total

1.  Exploration of Streptococcus core genome to reveal druggable targets and novel therapeutics against S. pneumoniae.

Authors:  Zeshan Mahmud Chowdhury; Arittra Bhattacharjee; Ishtiaque Ahammad; Mohammad Uzzal Hossain; Abdullah All Jaber; Anisur Rahman; Preonath Chondrow Dev; Md Salimullah; Chaman Ara Keya
Journal:  PLoS One       Date:  2022-08-18       Impact factor: 3.752

2.  Country data on AMR in Vietnam in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicines and clinical outcome.

Authors:  Didem Torumkuney; Subhashri Kundu; Giap Van Vu; Hoang Anh Nguyen; Hung Van Pham; Praveen Kamble; Ngoc Truong Ha Lan; Nergis Keles
Journal:  J Antimicrob Chemother       Date:  2022-09-06       Impact factor: 5.758

3.  Cephalosporins-induced intestinal dysbiosis exacerbated pulmonary endothelial barrier disruption in streptococcus pneumoniae-infected mice.

Authors:  Jia-Feng Wang; Chang-Yi Shi; Hua-Zhong Ying
Journal:  Front Cell Infect Microbiol       Date:  2022-08-24       Impact factor: 6.073

4.  Predicting Oral Beta-lactam susceptibilities against Streptococcus pneumoniae.

Authors:  Mark E Murphy; Eleanor Powell; Joshua Courter; Joel E Mortensen
Journal:  BMC Infect Dis       Date:  2021-07-13       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.